Orion Oyj (HEL:ORNAV)
Finland
· Delayed Price · Currency is EUR 62.30
+0.20 (0.32%)
Jun 6, 2025, 6:29 PM EET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2011 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2011 - 2019 |
| Sale of Goods |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sale of Goods Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Royalty Income |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Royalty Income Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Milestone Payments |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Milestone Payments Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Animal Health |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Animal Health Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Fermion |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Fermion Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Translation Differences and Other Operations |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Translation Differences and Other Operations Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Innovative Medicines |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Innovative Medicines Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Branded Products |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Branded Products Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Generics and Consumer Health |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Generics and Consumer Health Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2011 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2011 - 2019 |
| Finland |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finland Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Scandinavia |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Scandinavia Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Europe |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Europe Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Markets |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Markets Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2011 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2011 - 2019 |
| Human Pharmaceuticals (Hospital and Pharmacy Channel) Reported Market Share |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Reference Priced Prescription Drugs (Pharmacy Channel) Reported Market Share |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Self-Care Products (Pharmacy Channel) Reported Market Share |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Prescription Drugs (Pharmacy Channel) Reported Market Share |
Log In |
Log In |
Log In |
Log In | Upgrade
|